Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis.
Hassan H, Allen I, Sofianopoulou E, Walburga Y, Turnbull C, Eccles DM, Tischkowitz M, Pharoah P, Antoniou AC.
Am J Obstet Gynecol. 2024 Jan;230(1):44-57. doi: 10.1016/j.ajog.2023.06.043. Epub 2023 Jun 25.
Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence.
Conduit C, Milne RL, Friedlander ML, Phillips KA.
Cancer Prev Res (Phila). 2021 Nov;14(11):983-994. doi: 10.1158/1940-6207.CAPR-21-0141. Epub 2021 Aug 4.
Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes.
Liu YL, Breen K, Catchings A, Ranganathan M, Latham A, Goldfrank DJ, Grisham RN, Long Roche K, Frey MK, Chi DS, Abu-Rustum N, Aghajanian C, Offit K, Stadler ZK.
JCO Oncol Pract. 2022 Mar;18(3):201-209. doi: 10.1200/OP.21.00382. Epub 2021 Sep 28.
Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
Scime NV, Brown HK, Metcalfe A, Simpson AN, Brennand EA.
Am J Obstet Gynecol. 2023 Dec;229(6):658.e1-658.e17. doi: 10.1016/j.ajog.2023.08.001. Epub 2023 Aug 6.
Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigation.
Morgan O, Belda R, Schnur J, Montgomery G, Parmar S, Chirivella I, Cano A.
Sex Med Rev. 2023 Dec 23;12(1):3-13. doi: 10.1093/sxmrev/qead020.
[Risk-reducing bilateral salpingo-oophorectomy: For whom, how and what results?].
Favier A, Evrevin C, Desseignés C, Benusiglio PR, Uzan C.
Bull Cancer. 2025 Mar;112(3):307-315. doi: 10.1016/j.bulcan.2024.05.007.
Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
Cusimano MC, Moineddin R, Chiu M, Ferguson SE, Aktar S, Liu N, Baxter NN.
Am J Obstet Gynecol. 2021 Jun;224(6):585.e1-585.e30. doi: 10.1016/j.ajog.2020.12.1206. Epub 2020 Dec 24.
Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Gasparri ML, Taghavi K, Fiacco E, Zuber V, Di Micco R, Gazzetta G, Valentini A, Mueller MD, Papadia A, Gentilini OD.
Medicina (Kaunas). 2019 Jul 29;55(8):415. doi: 10.3390/medicina55080415.
Unnecessary bilateral salpingo-oophorectomy at the time of hysterectomy and potential for ovarian preservation.
Wong J, Murji A, Sunderji Z, Chow O, Shapiro J, Wolfman W, Shirreff L.
Menopause. 2020 Sep 4;28(1):8-11. doi: 10.1097/GME.0000000000001652.
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO.
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
